Probiotics around the time of birth have been found to reduce the risk of AD both in the ProPACT study [11, 17] and meta-analyses [12], and the current study aimed to investigate if the preventive effect could be partially due to long term effects on the systemic inflammatory proteins of their offspring. This evidence concerns the gene PROS1 and Alzheimer disease.